Clinical Trials Browser

Phase 1 × Mesothelin-positive Advanced Refractory Solid Tumors × Cyclophosphamide × Clear all

NCT05531708 2023-03-01

Exploratory Study of Novel MSLN CAR-T Cell Therapy in Patients With MSLN-positive Advanced Refractory Solid Tumors

Phase 1 Withdrawn

Other solid neoplasm

Mesothelin-positive Advanced Refractory Solid Tumors